Salt 00003

MicroSalt makes a patented natural salt containing 50% less sodium than the traditional offering

Shares in low-sodium salt manufacturer MicroSalt have rallied from a year low, after a trading update revealed sales had beaten an upgraded forecast of $2m (£1.5m) in FY25.

Shares leaped 21% to 51.9p as markets opened in London today. Taking $2.1m in unaudited sales in the year to 31 December 2025, MicroSalt grew revenues 287% year on year from $745k.

The company said it expected rapid growth to continue, and has projected sales of $7m for 2026, and more than $15m for 2027, as CEO Rick Guiney said the team was “immensely proud” of its 2025 performance.

“This performance is a clear testament to the strength of our offering, the versatility of MicroSalt’s applications, and the successful execution of our strategy to build a sustainable and profitable organisation,” he said.

Part of the company’s anticipated strong performance has come from upgraded volume projections from an unnamed ‘Customer 3’ – “one of the world’s largest food, soft drink and snack manufacturers”. 

“The increased volume projections included a new product that is due to commence in Q2 2026,” MicroSalt said in its trading statement.

“The company’s first bulk order for this product has been delivered for a specific end retailer of Customer 3. In addition, further similar orders have been received on a broadly monthly basis since, in line with management expectations.”

MicroSalt’s upgraded expectations followed the announcement of a new customer, the dairy-free manufacturer Daiya Foods in late 2025, predicted to bring approximately $500k in revenue in 2026.

The company’s positive momentum has helped it push towards its mission of delivering healthier food alternatives globally, according to Guiney.

“Our final 2025 healthy servings totalled 830,735,462, providing clear evidence that MicroSalt is successfully delivering on its mission of enabling healthier foods by helping to reduce excess sodium consumption,” he said.

MicroSalt produces a patented natural salt containing 50% less sodium than the traditional offering. The company floated on London’s junior market in early 2024 with a market cap of £18.5m.